Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis-Reference-Cited by-同舟云学术

Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis

Published:2019-12-27 Issue:1 Volume:72 Page:137-149
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis Rheumatol

Author:

Soare Alina¹^ORCID,Györfi Hermina A.²,Matei Alexandru E.²^ORCID,Dees Clara²,Rauber Simon²,Wohlfahrt Thomas²,Chen Chih‐Wei²,Ludolph Ingo²,Horch Raymund E.²,Bäuerle Tobias³,Hörsten Stephan²,Mihai Carina⁴,Distler Oliver⁵^ORCID,Ramming Andreas²,Schett Georg²^ORCID,Distler Jörg H. W.²^ORCID

Affiliation:

1. Friedrich‐Alexander University Erlangen‐Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany, and Davila University of Medicine and Pharmacy Bucharest Romania

2. Friedrich‐Alexander University Erlangen‐Nuremberg and Universitätsklinikum Erlangen Erlangen Germany

3. Friedrich‐Alexander University Erlangen‐Nuremberg Erlangen Germany

4. University Hospital Zurich, Zurich, Switzerland, and Carol Davila University of Medicine and Pharmacy Bucharest Romania

5. University Hospital Zurich Zurich Switzerland

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41058